B

Barinthus Biotherapeutics plc
D

BRNS

0.57750
USD
0.00
(0.63%)
مغلق
حجم التداول
0
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
23,590,236
المقالات
المزيد

العنوان: Barinthus Biotherapeutics plc

القطاع: Healthcare
الصناعة: Biotechnology
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapeutic drug candidates for treating autoimmune and inflammatory diseases. The company is prioritizing the development of itsproprietary SNAP-TI platform, designed to promote immune tolerance, with its lead candidate VTP-1000 targeting celiac disease. It is also developing VTP-300 for chronic hepatitis B using viral vector platform technologies, aimed at inducing disease-specific immune responses.